PlanetRx.com
This article was originally published in The Tan Sheet
Executive Summary
E-tailer verging on NASDAQ delisting as stock fails to remain above the $1 minimum bid price. Company's troubles follow a last-ditch, 8-for-1 reverse stock split cleared by the exchange Dec. 1. Since October, the company has not managed to raise stock prices above 50[cents], closing at 31[cents] Jan. 5. PlanetRx's delisting has been stayed pending a qualifications panel hearing, the company said
You may also be interested in...
Drugstore.com Improved Sales "Surprise Ourselves And Everybody Else"
Indications drugstore.com has surpassed fourth quarter sales estimates by roughly 20% exceed even company expectations, Chairman and CEO Peter Neupert said at a Morgan Stanley Dean Witter conference in Scottsdale, Ariz. Jan. 8.
Drugstore.com Improved Sales "Surprise Ourselves And Everybody Else"
Indications drugstore.com has surpassed fourth quarter sales estimates by roughly 20% exceed even company expectations, Chairman and CEO Peter Neupert said at a Morgan Stanley Dean Witter conference in Scottsdale, Ariz. Jan. 8.
Drugstore.com Improved Sales "Surprise Ourselves And Everybody Else"
Indications drugstore.com has surpassed fourth quarter sales estimates by roughly 20% exceed even company expectations, Chairman and CEO Peter Neupert said at a Morgan Stanley Dean Witter conference in Scottsdale, Ariz. Jan. 8.